BRIEF published on 04/07/2026 at 14:47, 5 months 25 days ago Evotec devrait empocher 100 millions de dollars grâce à la vente de Tubulis. Conjugués Anticorps-médicament Evotec Tubulis Stratégie De Monétisation Sciences De Gilead
BRIEF published on 04/07/2026 at 14:47, 5 months 25 days ago Evotec to Gain $100 Million from Tubulis Sale Antibody-drug Conjugates Evotec Tubulis Monetization Strategy Gilead Sciences
PRESS RELEASE published on 04/07/2026 at 14:42, 5 months 25 days ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition Evotec SE to receive approximately $100 million as part of Tubulis acquisition, marking continued execution of portfolio monetization strategy Acquisition Investment Monetization Evotec Tubulis
BRIEF published on 04/07/2026 at 07:35, 5 months 26 days ago Evotec Proposes Dieter Weinand as New Supervisory Board Chairman Strategic Partnerships Supervisory Board Evotec Pharmaceutical Leadership Dieter Weinand
BRIEF published on 04/07/2026 at 07:35, 5 months 26 days ago Evotec propose Dieter Weinand comme nouveau président du conseil de surveillance Partenariats Stratégiques Conseil De Surveillance Evotec Leadership Pharmaceutique Dieter Weinand
PRESS RELEASE published on 04/07/2026 at 07:30, 5 months 26 days ago Evotec Nominates Dieter Weinand as Supervisory Board Chairman Evotec SE nominates Dieter Weinand as Supervisory Board Chairman, aiming to enhance commercial execution, strategic partnerships, and profitability Strategic Partnerships Supervisory Board Chairman Evotec SE Commercial Execution Dieter Weinand
BRIEF published on 04/01/2026 at 11:15, 6 months 2 days ago Evotec SE to Release 2025 Financial Results Financial Results Drug Discovery Evotec SE Webcast 2025 Performance
BRIEF published on 04/01/2026 at 11:15, 6 months 2 days ago Evotec SE publiera ses résultats financiers de 2025 Résultats Financiers Evotec SE Webdiffusion Découverte De Médicaments Performances 2025
PRESS RELEASE published on 04/01/2026 at 11:10, 6 months 2 days ago Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 Evotec SE will announce its Q4 and full-year 2025 financial results on April 8, 2026, through a webcast and conference call held in English. Learn more at www.evotec.com Financial Results Conference Call Drug Discovery Evotec SE Webcast
BRIEF published on 04/01/2026 at 07:35, 6 months 2 days ago Evotec nomme le Dr Ashiq H. Khan au poste de directeur commercial Biotechnologie Direction Stratégie Commerciale Evotec Innovation En IA
Published on 10/03/2026 at 02:35, 12 hours 5 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 1 hour ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 1 hour ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 23:55, 14 hours 44 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 18 hours 16 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 18 hours 53 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 19 hours 40 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 18:00, 20 hours 40 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 20 hours 55 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 20 hours 55 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 21 hours 5 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 21 hours 10 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 21 hours 10 minutes ago Aéroports de Paris SA - Calendrier financier 2027
